We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Neurostimulation System Significantly Reduces Tinnitus

By HospiMedica International staff writers
Posted on 26 Oct 2020
Print article
Image: Simultaneously stimulating the tongue and auditory system can treat tinnitus (Photo courtesy of Neuromod Devices)
Image: Simultaneously stimulating the tongue and auditory system can treat tinnitus (Photo courtesy of Neuromod Devices)
A neuromodulation device that combines sound and electrical stimulation of the tongue can significantly reduce tinnitus symptoms.

The Neuromod Devices (Dublin, Ireland) Lenire system consists of a pair of Bluetooth wireless headphones that deliver sequences of audio tones (layered with wideband noise) to both ears, which is combined with electrical stimulation pulses delivered to 32 electrodes on the tip of the tongue by a proprietary device called the Tonguetip. Timing, intensity, and delivery of the stimuli are self-controlled by an easy-to-use handheld controller. Before first using the device, it is configured to a patient’s hearing profile and optimized to the patient’s sensitivity level for tongue stimulation.

In a study of the Lenire, 326 participants were instructed to use the device for 60 minutes daily for a period of 12 weeks. When treatment was completed, the participants returned their devices and were assessed at three follow-up visits for up to 12 months. About two-thirds of the participants affirmed they had benefited from using the device, with many experiencing sustained benefit 12 months post-treatment, and 77.8% said they would recommend it for other people with tinnitus.

“This study tracked the post-treatment therapeutic effects for 12 months, which is a first for the tinnitus field in evaluating the long-term outcomes of a medical device approach,” said Hubert Lim, PhD, of the University of Minnesota, and chief scientific officer of Neuromod Devices. “The outcomes are very exciting, and I look forward to continuing our work to develop a bimodal neuromodulation treatment to help as many tinnitus sufferers as possible.”

Tinnitus is the perception of sound within the human ear when no actual sound is present. It is not a disease, but a condition that can result from a wide range of underlying causes, including neurological damage, ear infections, oxidative stress, foreign objects, nasal allergies, wax build-up, and exposure to loud sounds. While it may be an accompaniment of sensorineural hearing loss or congenital hearing loss, or a side effect of certain medications, the most common cause is noise-induced hearing loss. Tinnitus is common, with about 20% of people between 55 and 65 years old report symptoms on a general health questionnaire, and 11.8% on more detailed tinnitus-specific questionnaires.

Related Links:
Neuromod Devices

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Enterprise Imaging & Reporting Solution
Syngo Carbon

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.